TAF II p170 inhibitors are a class of chemical compounds that target the transcription-associated factor II p170 (TAF II p170), a component of the transcription factor IID (TFIID) complex. TAF II p170 plays a critical role in the regulation of gene transcription by acting as a co-activator in the assembly of the transcription pre-initiation complex. This protein is involved in the recognition of promoter regions of genes and helps to recruit RNA polymerase II to initiate transcription. TAF II p170 interacts with both the TATA-binding protein (TBP) and other TAFs within the TFIID complex, making it essential for the proper regulation of gene expression in eukaryotic cells. Inhibitors of TAF II p170 disrupt its function within the TFIID complex, thereby affecting the transcriptional machinery's ability to initiate and regulate the expression of specific genes.
The mechanism of action for TAF II p170 inhibitors generally involves binding to key domains of the protein, preventing it from interacting with other components of the transcription machinery, such as TBP or RNA polymerase II. By interfering with these interactions, TAF II p170 inhibitors block the formation of the transcription pre-initiation complex, leading to a reduction in gene transcription. This inhibition can cause widespread changes in gene expression patterns, impacting cellular processes that depend on the timely and regulated activation of transcription. These inhibitors provide valuable insights into the role of TAF II p170 in the regulation of gene expression and the broader dynamics of transcriptional control. By studying the effects of inhibiting TAF II p170, researchers can explore the complexities of transcriptional regulation and the essential components required for gene activation in eukaryotic cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Inhibits transcription by targeting RNA polymerase II, potentially affecting TAF15-mediated transcription. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Cyclin-dependent kinase inhibitor, affecting transcription regulation and possibly influencing TAF15. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II phosphorylation, potentially impacting TAF15 function in transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially affecting TAF15-mediated transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Inhibits RNA polymerase II, potentially altering transcription processes involving TAF15. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BET family of bromodomain proteins, potentially influencing transcription factors including TAF15. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor, could alter transcriptional regulation affecting TAF15's role. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $61.00 $85.00 | 4 | |
Aurora kinase inhibitor, can indirectly affect transcriptional regulation and TAF15 function. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Inhibits eukaryotic initiation factor 4A, indirectly affecting transcription and possibly TAF15. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits protein synthesis, potentially influencing cellular responses that include TAF15 activity. | ||||||